A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and Open Label
Controlled, Parallel Group Study to Assess the Effects of HM11260C and an Active Comparator
on Gastric Emptying and Beta-Cell Response in Subjects with Type 2 Diabetes Mellitus